|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/17 | |
| C07K 14/715 |
| (11) | Number of the document | 2968454 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14718264.6 |
| Date of filing the European patent application | 2014-03-14 | |
| (97) | Date of publication of the European application | 2016-01-20 |
| (45) | Date of publication and mention of the grant of the patent | 2019-02-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/027058 |
| Date | 2014-03-14 |
| (87) | Number | WO 2014/152195 |
| Date | 2014-09-25 |
| (30) | Number | Date | Country code |
| 201361787121 P | 2013-03-15 | US | |
| 201361819029 P | 2013-05-03 | US | |
| 201361913417 P | 2013-12-09 | US |
| (72) |
MURPHY, Andrew, J., US
PAPADOPOULOS, Nicholas, J., US
ORENGO, Jamie, US
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (54) | IL-33 ANTAGONISTS AND USES THEREOF |
| IL-33 ANTAGONISTS AND USES THEREOF |